Literature DB >> 3972990

Comparison of basal media for culturing Campylobacter jejuni and Campylobacter coli.

L K Ng, M E Stiles, D E Taylor.   

Abstract

Four strains of Campylobacter jejuni and four strains of Campylobacter coli were used to compare the quantitative growth of Campylobacter cells on blood agar base no. 2 (Oxoid), brucella agar (BBL Microbiology Systems and Difco Laboratories), campylobacter agar base (Difco), Columbia blood agar base (Difco and Oxoid), and Mueller-Hinton agar (Difco and Oxoid). Columbia blood agar base and blood agar base no. 2 were inhibitory to most of the strains tested, as evidenced by reduced (10- to 1,000-fold) colony counts compared with other basal media. One of the brucella agars was inhibitory to two of the C. coli strains. The inhibitory effect of these media could be eliminated by addition of FBP (0.05% each ferrous sulfate hydrate, sodium metabisulfite, and sodium pyruvate) or 7% defibrinated sheep blood. However, addition of FBP or blood to brucella agar, campylobacter agar base, or Mueller-Hinton agar did not significantly affect the count, indicating that supplements are not required in these media for growth of Campylobacter in pure culture.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972990      PMCID: PMC271618          DOI: 10.1128/jcm.21.2.226-230.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Stimulatory effect of dihydroxyphenyl compounds on the aerotolerance of Spirillum volutans and Campylobacter fetus subspecies jejuni.

Authors:  J H Bowdre; N R Krieg; P S Hoffman; R M Smibert
Journal:  Appl Environ Microbiol       Date:  1976-01       Impact factor: 4.792

2.  Acute enteritis due to related vibrio: first positive stool cultures.

Authors:  P Dekeyser; M Gossuin-Detrain; J P Butzler; J Sternon
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

3.  Effect of ferrous sulfate, sodium metabisulfite, and sodium pyruvate on survival of Campylobacter jejuni.

Authors:  S P Chou; R Dular; S Kasatiya
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

4.  Campylobacter enteritis in Brussels.

Authors:  S Lauwers; M De Boeck; J P Butzler
Journal:  Lancet       Date:  1978-03-18       Impact factor: 79.321

5.  Studies of the microaerophilic nature of Campylobacter fetus subsp. jejuni. I. Physiological aspects of enhanced aerotolerance.

Authors:  P S Hoffman; N R Krieg; R M Smibert
Journal:  Can J Microbiol       Date:  1979-01       Impact factor: 2.419

6.  Molecular identification of surface protein antigens of Campylobacter jejuni.

Authors:  S M Logan; T J Trust
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

7.  Trimethoprim activity in media selective for Campylobacter jejuni.

Authors:  C A Bopp; J G Wells; T J Barrett
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

8.  Selective enrichment broth medium for isolation of Campylobacter jejuni.

Authors:  W T Martin; C M Patton; G K Morris; M E Potter; N D Puhr
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

9.  Isolation and enumeration of Campylobacter jejuni from poultry products by a selective enrichment method.

Authors:  R D Wesley; B Swaminathan; W J Stadelman
Journal:  Appl Environ Microbiol       Date:  1983-11       Impact factor: 4.792

10.  Biphasic culture system for rapid Campylobacter cultivation.

Authors:  D M Rollins; J C Coolbaugh; R I Walker; E Weiss
Journal:  Appl Environ Microbiol       Date:  1983-01       Impact factor: 4.792

View more
  10 in total

1.  Multi-step optimization of the filtration method for the isolation of Campylobacter species from stool samples.

Authors:  Anne Tilmanne; Helga Marisca Kandet Yattara; Margaux Herpol; Linda Vlaes; Patricia Retore; Caroline Quach; Olivier Vandenberg; Marie Hallin; Delphine Martiny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-04       Impact factor: 3.267

2.  Plasmid-mediated tetracycline resistance in Campylobacter jejuni: expression in Escherichia coli and identification of homology with streptococcal class M determinant.

Authors:  D E Taylor
Journal:  J Bacteriol       Date:  1986-03       Impact factor: 3.490

Review 3.  Pathophysiology of Campylobacter enteritis.

Authors:  R I Walker; M B Caldwell; E C Lee; P Guerry; T J Trust; G M Ruiz-Palacios
Journal:  Microbiol Rev       Date:  1986-03

4.  Helicobacter winghamensis sp. nov., a novel Helicobacter sp. isolated from patients with gastroenteritis.

Authors:  P L Melito; C Munro; P R Chipman; D L Woodward; T F Booth; F G Rodgers
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

5.  A blood-free medium for isolation of thermophilic Campylobacter species.

Authors:  H W Van Landuyt; J M Fossépré; B Gordts
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

6.  A Comparative Evaluation Study of Growth Conditions for Culturing the Isolates of Campylobacter spp.

Authors:  Ying-Hsin Hsieh; Steven Simpson; Khalil Kerdahi; Irshad M Sulaiman
Journal:  Curr Microbiol       Date:  2017-09-08       Impact factor: 2.188

7.  Transition-State Analogues of Campylobacter jejuni 5'-Methylthioadenosine Nucleosidase.

Authors:  Rodrigo G Ducati; Rajesh K Harijan; Scott A Cameron; Peter C Tyler; Gary B Evans; Vern L Schramm
Journal:  ACS Chem Biol       Date:  2018-10-19       Impact factor: 5.100

8.  Growth and laboratory maintenance of Campylobacter jejuni.

Authors:  Lindsay Davis; Victor DiRita
Journal:  Curr Protoc Microbiol       Date:  2008-08

9.  Inhibition of Campylobacter coli and Campylobacter jejuni by antibiotics used in selective growth media.

Authors:  L K Ng; M E Stiles; D E Taylor
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

10.  Phenotypes of Campylobacter jejuni luxS mutants are depending on strain background, kind of mutation and experimental conditions.

Authors:  Linda Adler; Thomas Alter; Soroush Sharbati; Greta Gölz
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.